Showing results (2571-2580 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|December 8, 2025
Evaluating Food and Drug Administration approved gastrointestinal cancer drugs: clinical benefit and trial endpoints over the past two decadesFares Jamal, Oudai Sahvan, Pedro Luiz Serrano Uson Junior, et al.
The Oncologist|June 21, 2025
Multimodal rehabilitation to improve quality of life and fatigue after radiotherapy in esophageal cancer patients: a randomized trialXianyan Chen, Linjun Zhong, Jiao Wang, et al.
The Oncologist|December 26, 2024
Patient-caregiver concordance on death preparedness over Taiwanese cancer patients' last 6 monthsFur-Hsing Wen, Chia-Hsun Hsieh, Wen-Chi Chou, et al.
The Oncologist|February 25, 2025
Plasma ctDNA kinetics as a predictor of systemic therapy response for advanced non-small cell lung cancer: a systematic review and meta-analysisLuís F Leite da Silva, Erick F Saldanha, Júnior Samuel Alonso de Menezes, et al.
The Oncologist|March 10, 2025
Prognostic relevance of immunoglobulin heavy chain rearrangement and immunoglobulin kappa light chain rearrangement in patients with diffuse large B cell lymphomaJie Wang, Sha Zhao, Ting Niu, et al.
The Oncologist|January 21, 2025
A phase II study of ramucirumab and somatostatin analog therapy in patients with advanced neuroendocrine tumorsKimberly Perez, Matthew H Kulke, Hui Zheng, et al.
The Oncologist|January 23, 2025
Is it time to retire preoperative radiation for localized esophageal and gastro-esophageal adenocarcinoma?Cindy M Pabon, Benjamin Spieler, Jenny J Li, et al.
The Oncologist|March 4, 2025
Predictors of advanced-stage presentation among patients with a diagnosis of breast and cervical cancer in EthiopiaBirtukan Shewarega, Sefonias Getachew, Nigussie Assefa Kassaw, et al.
The Oncologist|December 14, 2024
Safety and quality of life with maintenance olaparib plus bevacizumab in older patients with ovarian cancer: subgroup analysis of PAOLA‑1/ENGOT-ov25Coline Montégut, Claire Falandry, Saverio Cinieri, et al.
The Oncologist|September 2, 2024
Molecular characterization of metastatic penile squamous cell carcinoma in developing countries and its impact on clinical outcomes: LACOG 2018 translational studyFernando Sabino Marques Monteiro, Antonio Machado Alencar Junior, Karine Martins da Trindade, et al.
Pageof 571